Henri A. Termeer Henri A. Termeer was chairman, president and chief executive officer of Genzyme Corporation for nearly three decades. Under his leadership, Genzyme grew from a modest entrepreneurial venture to one of the world’s leading biotechnology companies.

Widely acknowledged for his contributions to the biotechnology industry and health care field, Mr. Termeer is active in the areas of humanitarian assistance, policy issues, and innovation in providing access to health care. He serves on the board of directors of the Pharmaceutical Research and Manufacturers of America. He is also a director of Massachusetts General Hospital, a board member of Partners HealthCare, a member of the board of fellows of Harvard Medical School, chairman of the Federal Reserve Bank of Boston’s board of directors, a member of Massachusetts Governor Deval Patrick’s Council of Economic Advisors, a trustee for the Boston Museum of Science, and a member of the Massachusetts Institute of Technology Corporation. Mr. Termeer has been recognized by several highly regarded organizations for his contributions to the health care field. In 2010, he was inducted into the Academy of Distinguished Entrepreneurs, which was established by Babson College to recognize the economic and social contributions of pioneering business people. Mr. Termeer received the Pharmaceuticals and Biotechnology Lifetime Achievement Award from Frost and Sullivan in 2009. Mr. Termeer was appointed president of Genzyme in 1983, two years after the company's founding. He became its chief executive officer in 1985 and chairman in 1988. Prior to joining Genzyme, he held various management positions over a 10-year period at Baxter Travenol (now Baxter International). Mr. Termeer studied economics at the Economische Hogeschool (Erasmus University, The Netherlands) and earned an M.B.A from the Darden School at the University of Virginia.